PAVmed Inc. (PAVM) Insider Trading Activity
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
PAVM Insider Trading Activity
PAVM Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
About PAVmed Inc.
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Insider Activity of PAVmed Inc.
Over the last 12 months, insiders at PAVmed Inc. have bought $0 and sold $0 worth of PAVmed Inc. stock.
On average, over the past 5 years, insiders at PAVmed Inc. have bought $96,666 and sold $755,649 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100,000 shares for transaction amount of $62,320 was made by Glennon Michael J (director) on 2022‑12‑07.
List of Insider Buy and Sell Transactions, PAVmed Inc.
| 2022-12-07 | Glennon Michael J | director | 100,000 0.1128% | $0.62 | $62,320 | -35.65% | ||
| 2022-12-06 | Glennon Michael J | director | 88,000 0.1032% | $0.64 | $56,082 | -34.43% | ||
| 2022-12-05 | Glennon Michael J | director | 62,000 0.0713% | $0.69 | $42,606 | -40.22% | ||
| 2021-03-18 | Aklog Lishan | Chairman and CEO | 7,500 0.0102% | $4.31 | $32,324 | +16.12% | ||
| 2020-11-25 | Sale | SIROVICH MATTHEW | 10 percent owner | 33,203 0.0686% | $1.96 | $65,048 | +158.16% | |
| 2020-11-24 | Sale | SIROVICH MATTHEW | 10 percent owner | 53,036 0.11% | $2.00 | $105,876 | +154.27% | |
| 2020-11-19 | Sale | SIROVICH MATTHEW | 10 percent owner | 75,211 0.1596% | $1.83 | $137,418 | +184.27% | |
| 2020-11-18 | Sale | SIROVICH MATTHEW | 10 percent owner | 24,789 0.0502% | $1.78 | $44,164 | +178.02% | |
| 2020-05-29 | Sale | SIROVICH MATTHEW | 10 percent owner | 131,082 0.2912% | $1.98 | $259,477 | +5.03% | |
| 2020-05-28 | Sale | SIROVICH MATTHEW | 10 percent owner | 69,839 0.162% | $2.06 | $143,666 | +5.56% | |
| 2019-05-24 | MCGRATH DENNIS M | President & CFO | 5,000 0.0184% | $1.09 | $5,429 | +1.87% | ||
| 2019-05-23 | Aklog Lishan | Chairman and CEO | 30,000 0.1072% | $1.09 | $32,850 | -1.80% | ||
| 2018-08-28 | Aklog Lishan | Chairman and CEO | 30,000 0.1084% | $1.18 | $35,400 | -12.20% | ||
| 2018-06-08 | Sale | Greenspan Ira Scott | 10 percent owner | 18,300 0.0967% | $1.04 | $19,032 | +10.49% | |
| 2018-06-01 | Sale | Greenspan Ira Scott | 10 percent owner | 532,255 2.6899% | $0.97 | $516,287 | +12.76% | |
| 2017-11-20 | Aklog Lishan | Chairman and CEO | 950 0.0075% | $4.70 | $4,465 | -66.22% | ||
| 2017-11-17 | Aklog Lishan | Chairman and CEO | 601 0.0045% | $4.37 | $2,626 | -65.13% | ||
| 2017-09-15 | Aklog Lishan | Chairman and CEO | 2,600 0.0238% | $8.77 | $22,814 | -76.88% | ||
| 2017-09-13 | Aklog Lishan | Chairman and CEO | 300 0.0022% | $6.88 | $2,065 | -76.78% | ||
| 2017-09-12 | Aklog Lishan | Chairman and CEO | 100 0.0007% | $6.66 | $666 | -76.29% |
Insider Historical Profitability
| Aklog Lishan | Chairman and CEO | 1105913 6.3675% | $807,427.08 | 48 | 0 | <0.0001% |
| SIROVICH MATTHEW | 10 percent owner | 1027744 5.9175% | $750,355.89 | 0 | 6 | |
| MCGRATH DENNIS M | President & CFO | 529000 3.0458% | $386,222.90 | 5 | 0 | <0.0001% |
| Greenspan Ira Scott | 10 percent owner | 421691 2.428% | $307,876.60 | 0 | 2 | |
| Glennon Michael J | director | 250000 1.4394% | $182,525.00 | 3 | 0 | <0.0001% |
| Fitzgerald Richard F | CFO and Secretary | 200 0.0012% | $146.02 | 2 | 0 | |
| Lamstein Joshua R | director | 100 0.0006% | $73.01 | 1 | 0 |
PAVM Institutional Investors: Active Positions
| Increased Positions | 7 | +20.59% | 192,578 | +19.88% |
| Decreased Positions | 11 | -32.35% | 53,699 | -5.54% |
| New Positions | 4 | New | 78,992 | New |
| Sold Out Positions | 5 | Sold Out | 49,946 | Sold Out |
| Total Postitions | 30 | -11.76% | 1M | +14.34% |
PAVM Ownership Change vs Market
Institutional Investor Ownership
| First Manhattan Co. Llc. | $553.00 | 4.12% | 700,000 | +100,000 | +16.67% | 2024-12-31 |
| Vanguard Group Inc | $64.00 | 0.48% | 81,494 | -199,521 | -71% | 2024-12-31 |
| Geode Capital Management, Llc | $63.00 | 0.47% | 79,470 | -3,026 | -3.67% | 2024-12-31 |
| Blackrock, Inc. | $57.00 | 0.43% | 72,660 | 0 | 0% | 2025-03-31 |
| Obermeyer Wealth Partners | $17.00 | 0.13% | 21,500 | 0 | 0% | 2024-12-31 |
| State Street Corp | $16.00 | 0.12% | 20,854 | 0 | 0% | 2024-12-31 |
| Ubs Group Ag | $10.00 | 0.08% | 12,787 | +12,778 | +141,977.78% | 2024-12-31 |
| Northern Trust Corp | $9.00 | 0.07% | 11,706 | 0 | 0% | 2024-12-31 |
| Exencial Wealth Advisors, Llc | $9.00 | 0.06% | 10,900 | +10,900 | New | 2024-12-31 |
| Xml Financial, Llc | $8.00 | 0.06% | 10,067 | 0 | 0% | 2025-03-31 |